NIMH Outreach Partnership
NAMI New Jersey is one of the 55 Outreach Partner organizations of the National Institute of Mental Health (NIMH) to conduct mental health outreach and education for the public, health professionals, K-12 schools, minorities and other populations such as youth and older adults using mental health-related information provided by NIMH or other sources.
The NIMH Outreach Partnership Program is a nationwide initiative of the National Institute of Mental Health (NIMH) with support from the National Institute on Drug Abuse (NIDA) and in cooperation with the Substance Abuse and Mental Health Services Administration (SAMHSA). The Program partners with national and state organizations to strengthen the public health impact of research by disseminating the latest scientific findings; informing the public about mental disorders, alcoholism, and drug addiction; and reducing the associated stigma and discrimination. The Program strives to increase public awareness about the important role of basic and clinical research in transforming the understanding and treatment of mental illnesses and addiction disorders, paving the way for prevention, recovery, and cure. The Program also provides NIMH with the opportunity to engage community organizations in a dialogue to help develop a national research agenda to improve America’s mental health.
Clinical Trial Participation Update
Find Clinical Trials by State:
For more information on research conducted by NIMH in Bethesda, MD click here www.nimh.nih.gov/JoinAStudy.
Understanding Depression in Teenagers
Join a research study seeking to understand the causes of depression in teenagers. As part of a larger study looking at mood dysregulation, participation begins with an initial 1-day outpatient evaluation. Research visits may include annual outpatient visits up to age 25, and/or 4- to 15-week inpatient treatment.
This part of the study is currently recruiting medically healthy teenagers, ages 12-17, who meet the criteria for major depressive disorder and are in treatment with a provider in their community. The study may include assessments, research testing, brain imaging, and standard medications, cognitive-behavioral therapy, psychological testing.
Enrollment is from across the United States. Transportation expenses to NIH in Bethesda, MD are reimbursed. There is no cost to participate, compensation is provided.
Call 1-301-496-8381 [TTY: 1-866-411-1010] or Email firstname.lastname@example.org.
Worry A Lot, Anxious, Shy, or Nervous in Social Situations?
Local Recruitment (Washington, D.C., Maryland, and Virginia)
This study seeks to better understand anxiety by examining changes in emotional reaction and task performance under stress. We want to understand the way these changes are different for people suffering from anxiety or mood disorders.
Participants must be 18 to 60, with generalized anxiety disorder, social anxiety disorder or a panic disorder. Participants must be free of certain medical conditions and currently not on psychiatric medications.
You may not be eligible if you are pregnant, have current alcohol or substance abuse problems, heart disease, neurological disease, or any health problems that would interfere with the study or make it unsafe for you.
Research procedures will include: a screening visit, 1 to 2 outpatient visits, computer tasks, exposure to unpleasant stimuli. Researchers will assess changes in heart rate, muscle activity, sweat responses and respiration. Visits may last up to 4 hours each.
This study is conducted at the NIH Clinical Center, Bethesda, MD.Compensation is provided.
Today’s Research on Medicines for Children Offers Hope for Tomorrow
Only 25 years ago, it was rare to find drug labels with dispensing information specific to children. That’s because pharmaceutical companies rarely, if ever, conducted the research necessary to develop such instructions. As a result, health care providers often gave children smaller doses of adult medicines, without evidence of how exactly the children would react. This blog post describes Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) activities to lead a nationwide initiative to include infants, children, and adolescents in drug research studies. In addition, it highlights the experiences of two families involved in NICHD-supported pediatric pharmacology research. https://www.nichd.nih.gov/news/resources/spotlight/Pages/012615-pharmacology.aspx
Join NIH Depression Research Studies
Does depression impede your daily life? Are you currently feeling sad and hopeless, experiencing worthlessness and guilt, and have a lack of interest in everyday activities you once enjoyed? NIH studies are investigating the brain and experimental medications (such as ketamine and diazoxide) to rapidly reduce depressive symptoms. Research includes: depressed adults ages 18 to 70, outpatient visits or inpatient stays of up to 12 weeks at the NIH Clinical Center in Bethesda, MD. Call 1-877-MIND-NIH, TTY: 1-866-411-1010. Email: email@example.com
Bipolar Disorder (Pediatric) Research Study: Treatment of Severe Mood Dysregulation
(Inpatient: 12-15 weeks) This study tests the efficacy of different treatments for decreasing irritability in children with severe mood and behavioral problems. Participants have symptoms of severe irritability and are not doing well on their current medications. The child must be currently in treatment with a physician, medically healthy, and not currently hospitalized, psychotic, or suicidal. The study includes day or full hospitalization to discontinue medication, followed by either methylphenidate plus citalopram, or methylphenidate plus placebo. Recruiting ages 7-17. [09-M-0034]
For more information on research conducted by NIMH in Bethesda, MD click here: www.nimh.nih.gov/JoinAStudy.
Nationwide Recruitment: Bipolar Disorder, Pediatric Research Study
Treatment of Severe Mood Dysregulation (SMD)
(Inpatient: 12- to 15 weeks) This study tests the efficacy of different treatments for decreasing irritability in children with severe mood and behavioral problems. Participants have symptoms of severe irritability and are not doing well on their current medications. The child must be currently in treatment with a physician, medically healthy and not currently hospitalized, psychotic or suicidal. The study includes day or full hospitalization to discontinue medication, followed by either methylphenidate plus citalopram, or methylphenidate plus placebo. Recruiting ages 7-17. [09-M-0034]
Nationwide Recruitment: NIH BIPOLAR DEPRESSION RESEARCH STUDIES ENROLLING PARTICIPANTS
IS YOUR BIPOLAR DEPRESSION HARD TO TREAT?
EXPERIENCING THOUGHTS OF SADNESS, HOPELESSNESS, GUILT, WORTHLESSNESS, LACKING INTEREST IN EVERYDAY ACTIVITIES YOU ONCE ENJOYED?
NIH researchers seek people between the ages of 18 and 70 with bipolar disorder, who are currently in a depressive phase, for participation in several brain imaging and medication studies that are evaluating how experimental medications (ketamine, riluzole, and scopolamine) may reduce symptoms rapidly. Participation includes one to four visits to the NIH Clinical Center in Bethesda, MD, psychiatric interviews, medical history, physical exam, and blood and other medical tests. Some studies are conducted on an outpatient basis, others on an inpatient basis. Participants must be free of other serious medical conditions. Research evaluations and medications are provided at no cost.
There is no cost to participate in the studies. NIMH enrolls eligible participants locally and from around the country. Travel arrangements are provided and costs covered by NIMH. (Arrangements vary by distance and by specific study.) After completing the study, participants receive short-term follow-up care while transitioning back to a provider in their community.
Atendemos pacientes de habla hispana.
Call: 1-877-MIND-NIH (1-877-646-3644)
Nationwide Recruitment: NIMH Adult Depression Research Study: Is Your Major Depression Hard to Treat?
This inpatient study is enrolling eligible participants to assess the effectiveness of the oral medication diazoxide versus placebo to rapidly improve hard-to-treat depressive symptoms. Eligibility criteria include people ages 18-65, who are diagnosed with Major Depressive Disorder (MDD), have previously failed to respond to treatment, and who are free of other serious medical conditions. This study can last up to 12 weeks and is conducted at the NIH Clinical Center in Bethesda, Maryland.
There is no cost to participate. We enroll eligible participants locally and from around the country. Travel arrangements are provided and costs are covered by NIMH (arrangements vary by distance). After completing the study, participants receive short-term follow-up care at the NIH while transitioning back to a provider.
For more information, call: 1-877-MIND-NIH (1-877-646-3644), TTY: 1-866-411-1010, or e-mail: firstname.lastname@example.org
Atendemos pacientes de habla hispana.
Participating in Alzheimer’s Research: For Yourself and Future Generations
Participating in Alzheimer’s Research: For Yourself and Future Generations is a new 20-page booklet from NIH. It can help individuals decide if participating in clinical research is right for them, a friend, or a family member. At least 70,000 volunteers are now needed for more than 150 Alzheimer’s and related clinical studies in the U.S. All kinds of people, including healthy older adults, can join in this research. http://www.nia.nih.gov/alzheimers/publication/participating-alzheimers-research